CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -5.9% | 11,604 | +20.8% | 0.00% | -50.0% |
| Q2 2022 | $17,000 | -74.6% | 9,604 | -62.0% | 0.00% | -66.7% |
| Q1 2022 | $67,000 | -38.0% | 25,304 | +0.6% | 0.01% | -33.3% |
| Q4 2021 | $108,000 | +145.5% | 25,154 | +269.9% | 0.01% | +80.0% |
| Q4 2020 | $44,000 | +109.5% | 6,800 | +161.5% | 0.01% | +66.7% |
| Q2 2020 | $21,000 | -46.2% | 2,600 | -51.9% | 0.00% | -25.0% |
| Q3 2019 | $39,000 | -47.3% | 5,400 | +33.5% | 0.00% | -20.0% |
| Q3 2018 | $74,000 | +34.5% | 4,046 | +65.9% | 0.01% | +25.0% |
| Q2 2018 | $55,000 | -15.4% | 2,439 | -21.7% | 0.00% | -33.3% |
| Q4 2017 | $65,000 | – | 3,115 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |